Average Ratings 0 Ratings
Average Ratings 1 Rating
Description
GPT-Rosalind is an advanced reasoning model created by OpenAI, aimed at enhancing scientific exploration in fields like biology, drug development, and translational medicine. Tailored for workflows in life sciences, it assists researchers in managing extensive literature, experimental findings, and specialized databases to formulate and test innovative concepts. By integrating a profound understanding of disciplines such as chemistry, genomics, protein engineering, and disease biology with sophisticated tool-usage capabilities, it effectively interacts with scientific databases, examines experimental results, and facilitates intricate, multi-stage reasoning tasks. Its functionalities span evidence synthesis, hypothesis formulation, literature assessment, sequence analysis, and experimental design, empowering scientists to transition more swiftly from raw data to meaningful insights. Furthermore, GPT-Rosalind revolutionizes cumbersome, time-consuming research methodologies into streamlined, AI-enhanced workflows, ultimately fostering a more productive scientific environment. This model exemplifies the fusion of artificial intelligence with scientific inquiry, paving the way for groundbreaking discoveries.
Description
OpenAI's advanced research tool utilizes artificial intelligence to independently carry out intricate, multi-step research tasks across a range of fields, including science, programming, and mathematics. By processing user inputs—such as questions, textual documents, images, PDFs, or spreadsheets—the tool creates a detailed research strategy, collects pertinent information, and provides thorough answers in just a few minutes. Additionally, it offers summaries of the research process with citations, enabling users to verify the sources of the information. Although this tool greatly enhances research efficiency, it can sometimes yield errors or have difficulty distinguishing between credible sources and false information. Currently, it is accessible to ChatGPT Pro users, marking a significant advancement in AI-assisted knowledge exploration, and further enhancements for accuracy and response speed are in the pipeline. This ongoing development reflects a commitment to refining the tool's capabilities and ensuring users receive the most reliable information.
API Access
Has API
Yes
API Access
Has API
No
Integrations
ChatGPT
Yes
OpenAI
Yes
ChatGPT Enterprise
No
ChatGPT Plus
No
ChatGPT Pro
No
Codex CLI
Yes
GPT-4o
No
GitHub
No
Microsoft 365 Copilot Analyst
No
Microsoft 365 Copilot Researcher
No
Integrations
ChatGPT
Yes
OpenAI
Yes
ChatGPT Enterprise
Yes
ChatGPT Plus
Yes
ChatGPT Pro
Yes
Codex CLI
No
GPT-4o
Yes
GitHub
Yes
Microsoft 365 Copilot Analyst
Yes
Microsoft 365 Copilot Researcher
Yes
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
Yes
iPad App
Yes
Android App
Yes
Windows
Yes
Mac
Yes
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
OpenAI
Founded
2015
Country
United States
Website
openai.com/index/introducing-gpt-rosalind/
Vendor Details
Company Name
OpenAI
Founded
2015
Country
United States
Website
openai.com/index/introducing-deep-research/
Product Features
Product Features
Artificial Intelligence
Chatbot
No
For Healthcare
No
For Sales
No
For eCommerce
No
Image Recognition
No
Machine Learning
No
Multi-Language
No
Natural Language Processing
No
Predictive Analytics
No
Process/Workflow Automation
No
Rules-Based Automation
No
Virtual Personal Assistant (VPA)
No